NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization

Abstract Nucleophosmin (NPM) mutations causing its export from the nucleoli to the cytoplasm are frequent in acute myeloid leukemia (AML). Due to heterooligomerization of wild type NPM with the AML-related mutant, the wild-type becomes misplaced from the nucleoli and its functions are significantly...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Markéta Šašinková, Petr Heřman, Aleš Holoubek, Dita Strachotová, Petra Otevřelová, Dana Grebeňová, Kateřina Kuželová, Barbora Brodská
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1b474fa87d0546bcb278d14120b4631c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1b474fa87d0546bcb278d14120b4631c
record_format dspace
spelling oai:doaj.org-article:1b474fa87d0546bcb278d14120b4631c2021-12-02T14:12:46ZNSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization10.1038/s41598-020-80224-12045-2322https://doaj.org/article/1b474fa87d0546bcb278d14120b4631c2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80224-1https://doaj.org/toc/2045-2322Abstract Nucleophosmin (NPM) mutations causing its export from the nucleoli to the cytoplasm are frequent in acute myeloid leukemia (AML). Due to heterooligomerization of wild type NPM with the AML-related mutant, the wild-type becomes misplaced from the nucleoli and its functions are significantly altered. Dissociation of NPM heterooligomers may thus restore the proper localization and function of wild-type NPM. NSC348884 is supposed to act as a potent inhibitor of NPM oligomerization. The effect of NSC348884 on the NPM oligomerization was thoroughly examined by fluorescence lifetime imaging with utilization of FRET and by a set of immunoprecipitation and electrophoretic methods. Leukemia-derived cell lines and primary AML cells as well as cells transfected with fluorescently labeled NPM forms were investigated. Our results clearly demonstrate that NSC348884 does not inhibit formation of NPM oligomers neither in vivo nor in vitro. Instead, we document that NSC348884 cytotoxicity is rather associated with modified cell adhesion signaling. The cytotoxic mechanism of NSC348884 has therefore to be reconsidered.Markéta ŠašinkováPetr HeřmanAleš HoloubekDita StrachotováPetra OtevřelováDana GrebeňováKateřina KuželováBarbora BrodskáNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Markéta Šašinková
Petr Heřman
Aleš Holoubek
Dita Strachotová
Petra Otevřelová
Dana Grebeňová
Kateřina Kuželová
Barbora Brodská
NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
description Abstract Nucleophosmin (NPM) mutations causing its export from the nucleoli to the cytoplasm are frequent in acute myeloid leukemia (AML). Due to heterooligomerization of wild type NPM with the AML-related mutant, the wild-type becomes misplaced from the nucleoli and its functions are significantly altered. Dissociation of NPM heterooligomers may thus restore the proper localization and function of wild-type NPM. NSC348884 is supposed to act as a potent inhibitor of NPM oligomerization. The effect of NSC348884 on the NPM oligomerization was thoroughly examined by fluorescence lifetime imaging with utilization of FRET and by a set of immunoprecipitation and electrophoretic methods. Leukemia-derived cell lines and primary AML cells as well as cells transfected with fluorescently labeled NPM forms were investigated. Our results clearly demonstrate that NSC348884 does not inhibit formation of NPM oligomers neither in vivo nor in vitro. Instead, we document that NSC348884 cytotoxicity is rather associated with modified cell adhesion signaling. The cytotoxic mechanism of NSC348884 has therefore to be reconsidered.
format article
author Markéta Šašinková
Petr Heřman
Aleš Holoubek
Dita Strachotová
Petra Otevřelová
Dana Grebeňová
Kateřina Kuželová
Barbora Brodská
author_facet Markéta Šašinková
Petr Heřman
Aleš Holoubek
Dita Strachotová
Petra Otevřelová
Dana Grebeňová
Kateřina Kuželová
Barbora Brodská
author_sort Markéta Šašinková
title NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
title_short NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
title_full NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
title_fullStr NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
title_full_unstemmed NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
title_sort nsc348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1b474fa87d0546bcb278d14120b4631c
work_keys_str_mv AT marketasasinkova nsc348884cytotoxicityisnotmediatedbyinhibitionofnucleophosminoligomerization
AT petrherman nsc348884cytotoxicityisnotmediatedbyinhibitionofnucleophosminoligomerization
AT alesholoubek nsc348884cytotoxicityisnotmediatedbyinhibitionofnucleophosminoligomerization
AT ditastrachotova nsc348884cytotoxicityisnotmediatedbyinhibitionofnucleophosminoligomerization
AT petraotevrelova nsc348884cytotoxicityisnotmediatedbyinhibitionofnucleophosminoligomerization
AT danagrebenova nsc348884cytotoxicityisnotmediatedbyinhibitionofnucleophosminoligomerization
AT katerinakuzelova nsc348884cytotoxicityisnotmediatedbyinhibitionofnucleophosminoligomerization
AT barborabrodska nsc348884cytotoxicityisnotmediatedbyinhibitionofnucleophosminoligomerization
_version_ 1718391772558655488